Polyclinique Bordeaux Nord

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer2 trials
• Colorectal cancer1 trial
• Mantle cell lymphoma1 trial
• Ovarian cancer1 trial
• Pancreatic cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Completed3 trials
• Active, not recruiting2 trials
• Terminated1 trial

Lead sponsor

• ARCAGY/ GINECO GROUP1 trial
• Eli Lilly and Company1 trial
• GERCOR - Multidisciplinary Oncology Cooperative Group1 trial
• Institut de Cancérologie de Lorraine1 trial
• The Lymphoma Academic Research Organisation1 trial
• and 1 more

Running trials

• Active, not recruiting

  LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy

  NCT04166604· Phase 2· GERCOR - Multidisciplinary Oncology Cooperative Group· Source

• Active, not recruiting

  A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

  NCT02246621· Phase 3· Eli Lilly and Company· Source

Closed trials

• Terminated

  Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment

  NCT06505018· UNICANCER· Source

• Completed

  Validation of KELIM as a Predictive/Prognostic Factor for Maintenance Treatment With iPARP in First-Line Ovarian Cancer

  NCT06660147· ARCAGY/ GINECO GROUP· Source

• Completed

  Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

  NCT02676349· Phase 2· Institut de Cancérologie de Lorraine· Source

• Completed

  R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL

  NCT01865110· Phase 3· The Lymphoma Academic Research Organisation· Source